Emcure launches Rs 8,790 a month semaglutide weight-loss drug in India
- Posted on December 22, 2025
- By Financial Express
- 2 Views
Emcure launches Rs 8,790 a month semaglutide weight-loss drug in India
In an exchange filing, the Pune-based drugmaker said it is the first Indian company to exclusively distribute and commercialise Poviztra, positioned as a second brand of Novo Nordisk’s semaglutide for weight management.
